CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Cancer Network
Original article

<![CDATA[Alliance A071801 Supports Fractionated SRS After Brain Metastasis Surgery]]>

Data ReadoutpositivePositive
AI Analysis

Summary

Alliance A071801 trial data supports fractionated stereotactic radiosurgery (SRS) over single-fraction SRS following brain metastasis resection. The findings were discussed by Dr. Ayal Aizer.

Clinical Trial Data

Primary Endpoint

Met

Outcome Details

Alliance A071801 data favored fractionated SRS over single-fraction SRS after brain metastasis resection

Importance:5/10
Sentiment:
0.60
oncologybrain metastasisstereotactic radiosurgerySRSclinical trial
Related Companies

Read the original article

Published by Cancer Network on October 3, 2026 4:00 PM

Read Original